STOCK TITAN

HCSG Reports Q4 2024 Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Healthcare Services Group (NASDAQ:HCSG) reported Q4 2024 results with revenue of $437.8 million and net income of $11.9 million, resulting in diluted EPS of $0.16. The company's housekeeping & laundry segment generated revenue of $192.7 million with a 10.2% margin, while dining & nutrition segment revenue was $245.1 million with a 4.7% margin.

Cash flow from operations was $36.2 million, with actual cash flow of $27.0 million after adjusting for payroll accrual. The company maintains a strong financial position with $135.8 million in cash and marketable securities, plus a $500.0 million credit facility.

Looking ahead, HCSG expects mid-single digit revenue growth in 2025, with Q1 revenue projected between $440.0 to $450.0 million. The company aims to manage cost of services in the 86% range and SG&A between 8.5% to 9.5%. 2025 cash flow from operations is expected to range from $45.0 to $60.0 million.

Healthcare Services Group (NASDAQ:HCSG) ha riportato i risultati del Q4 2024 con un fatturato di 437,8 milioni di dollari e un utile netto di 11,9 milioni di dollari, risultando in un EPS diluito di $0,16. Il segmento di pulizia e lavanderia dell'azienda ha generato un fatturato di 192,7 milioni di dollari con un margine del 10,2%, mentre il fatturato del segmento di ristorazione e nutrizione è stato di 245,1 milioni di dollari con un margine del 4,7%.

Il flusso di cassa dalle operazioni è stato di 36,2 milioni di dollari, con un flusso di cassa effettivo di 27,0 milioni di dollari dopo l'aggiustamento per l'accantonamento degli stipendi. L'azienda mantiene una solida posizione finanziaria con 135,8 milioni di dollari in contanti e titoli negoziabili, oltre a una linea di credito di 500,0 milioni di dollari.

Guardando al futuro, HCSG prevede una crescita del fatturato a cifre singole nel 2025, con un fatturato previsto per il Q1 compreso tra 440,0 e 450,0 milioni di dollari. L'azienda punta a gestire il costo dei servizi nella fascia dell'86% e le spese generali e amministrative tra l'8,5% e il 9,5%. Si prevede che il flusso di cassa dalle operazioni nel 2025 varierà da 45,0 a 60,0 milioni di dollari.

Healthcare Services Group (NASDAQ:HCSG) reportó los resultados del Q4 2024 con ingresos de 437.8 millones de dólares y un ingreso neto de 11.9 millones de dólares, resultando en un EPS diluido de $0.16. El segmento de limpieza y lavandería de la empresa generó ingresos de 192.7 millones de dólares con un margen del 10.2%, mientras que los ingresos del segmento de alimentación y nutrición fueron de 245.1 millones de dólares con un margen del 4.7%.

El flujo de efectivo de las operaciones fue de 36.2 millones de dólares, con un flujo de efectivo real de 27.0 millones de dólares después de ajustar por la acumulación de nómina. La empresa mantiene una sólida posición financiera con 135.8 millones de dólares en efectivo y valores negociables, además de una línea de crédito de 500.0 millones de dólares.

De cara al futuro, HCSG espera un crecimiento de ingresos de cifras de un solo dígito en 2025, con ingresos proyectados para el Q1 entre 440.0 y 450.0 millones de dólares. La empresa tiene como objetivo gestionar el costo de los servicios en el rango del 86% y los gastos generales y administrativos entre el 8.5% y el 9.5%. Se espera que el flujo de efectivo de las operaciones en 2025 oscile entre 45.0 y 60.0 millones de dólares.

Healthcare Services Group (NASDAQ:HCSG)는 2024년 4분기 결과를 보고하며, 매출은 4억 3,780만 달러였고, 순이익은 1,190만 달러로 희석주당순이익(EPS)은 $0.16에 달했습니다. 회사의 청소 및 세탁 부문은 1억 9,270만 달러의 매출을 기록했으며, 10.2%의 마진을 보였고, 식사 및 영양 부문은 2억 4,510만 달러의 매출을 올렸으며, 4.7%의 마진을 기록했습니다.

운영에서의 현금 흐름은 3,620만 달러였으며, 급여 발생을 조정한 후 실제 현금 흐름은 2,700만 달러였습니다. 회사는 1억 3,580만 달러의 현금 및 유가 증권과 5억 달러의 신용 시설을 보유하며 강력한 재무 상태를 유지하고 있습니다.

앞으로 HCSG는 2025년에 중간 단일 자릿수의 매출 성장을 예상하며, 1분기 매출은 4억 4,000만에서 4억 5,000만 달러 사이로 예상하고 있습니다. 회사는 서비스 비용을 86% 범위 내에서 관리하고, SG&A를 8.5%에서 9.5% 사이로 유지하는 것을 목표로 하고 있습니다. 2025년 운영에서의 현금 흐름은 4,500만에서 6,000만 달러 사이로 예상됩니다.

Healthcare Services Group (NASDAQ:HCSG) a rapporté les résultats du Q4 2024 avec des revenus de 437,8 millions de dollars et un revenu net de 11,9 millions de dollars, ce qui donne un BPA dilué de 0,16 $. Le segment nettoyage et blanchisserie de l'entreprise a généré des revenus de 192,7 millions de dollars avec une marge de 10,2%, tandis que les revenus du segment restauration et nutrition s'élevaient à 245,1 millions de dollars avec une marge de 4,7%.

Le flux de trésorerie provenant des opérations s'élevait à 36,2 millions de dollars, avec un flux de trésorerie réel de 27,0 millions de dollars après ajustement pour les provisions de paie. L'entreprise maintient une solide position financière avec 135,8 millions de dollars en liquidités et titres négociables, ainsi qu'une ligne de crédit de 500,0 millions de dollars.

En regardant vers l'avenir, HCSG s'attend à une croissance des revenus à un chiffre unique en 2025, avec des revenus projetés pour le Q1 compris entre 440,0 et 450,0 millions de dollars. L'entreprise vise à gérer le coût des services dans la fourchette de 86% et les SG&A entre 8,5% et 9,5%. Le flux de trésorerie provenant des opérations en 2025 est prévu entre 45,0 et 60,0 millions de dollars.

Healthcare Services Group (NASDAQ:HCSG) berichtete über die Ergebnisse des Q4 2024 mit einem Umsatz von 437,8 Millionen Dollar und einem Nettogewinn von 11,9 Millionen Dollar, was zu einem verwässerten EPS von $0,16 führte. Das Segment Reinigung und Wäsche des Unternehmens erzielte einen Umsatz von 192,7 Millionen Dollar mit einer Marge von 10,2%, während der Umsatz des Segments Essen und Ernährung 245,1 Millionen Dollar mit einer Marge von 4,7% betrug.

Der Cashflow aus dem operativen Geschäft betrug 36,2 Millionen Dollar, wobei der tatsächliche Cashflow nach Anpassung für Lohnrückstellungen 27,0 Millionen Dollar betrug. Das Unternehmen hält eine starke Finanzlage mit 135,8 Millionen Dollar an Bargeld und handelbaren Wertpapieren sowie einer Kreditlinie von 500,0 Millionen Dollar.

Für die Zukunft erwartet HCSG ein Umsatzwachstum im mittleren einstelligen Bereich im Jahr 2025, wobei der Umsatz für das Q1 zwischen 440,0 und 450,0 Millionen Dollar prognostiziert wird. Das Unternehmen strebt an, die Kosten der Dienstleistungen im Bereich von 86% zu verwalten und die SG&A zwischen 8,5% und 9,5% zu halten. Der Cashflow aus dem operativen Geschäft wird für 2025 auf einen Bereich von 45,0 bis 60,0 Millionen Dollar geschätzt.

Positive
  • Revenue increased to $437.8 million in Q4 2024 from $423.8 million in Q4 2023
  • Projects mid-single digit revenue growth for 2025
  • Strong liquidity position with $135.8 million in cash and marketable securities
  • Maintains $500 million credit facility through November 2027
Negative
  • Net income decreased to $11.9 million in Q4 2024 from $23.5 million in Q4 2023
  • Operating margin declined to 4.6% in Q4 2024 from 9.1% in Q4 2023
  • Cost of services increased to 86.6% of revenue
  • SG&A remains elevated at 10.1% of revenue, above target range of 8.5-9.5%

Insights

The Q4 2024 results reveal HCSG's strategic pivot from recovery to growth, marked by several key developments. The 86.6% cost of services ratio, while elevated due to new business start-up costs, demonstrates management's operational discipline with a clear path to optimization in 2025. The company's segment performance shows particular strength in Housekeeping & Laundry with a 10.2% margin, significantly outperforming the Dining & Nutrition segment's 4.7% margin.

The robust liquidity position, including $135.8 million in cash and marketable securities plus a $500 million credit facility, provides substantial financial flexibility for growth initiatives. The company's focus on working capital management is evident in the $27.0 million adjusted operating cash flow, though this represents a slight year-over-year decline from $27.9 million in Q4 2023.

Management's 2025 guidance suggests confidence in sustainable growth, with projected cash flow from operations of $45-60 million. The targeted SG&A reduction to 8.5-9.5% of revenue, down from the current 10.1%, indicates potential margin expansion through operational leverage. The ongoing share repurchase program, with $5 million executed in 2024, reflects management's commitment to shareholder returns while maintaining strategic flexibility.

Delivers Strong Earnings & Cash Flow,

Provides 2025 Growth Expectations
 

  • Revenue of $437.8 million.
  • Net income and diluted EPS of $11.9 million and $0.16, inclusive of new business start-up costs.
  • Reported cash flow from operations of $36.2 million; actual cash flow from operations, excluding the change in payroll accrual, of $27.0 million.
  • Expects mid-single digit revenue growth in 2025 and Q1 revenue in the range of $440.0 to $450.0 million.
  • Expects 2025 actual cash flow from operations, excluding the change in payroll accrual, in the range of $45.0 to $60.0 million.

BENSALEM, Pa.--(BUSINESS WIRE)-- Healthcare Services Group, Inc. (NASDAQ:HCSG) today reported results for the three months ended December 31, 2024.

Ted Wahl, Chief Executive Officer, stated, “2024 was a transitional year for HCSG, as it marked a pivotal shift from recovery to renewed growth. This shift was highlighted by our Q4 results and the positive momentum we’re carrying into the new year. Looking ahead, we are confident that continuing to execute on our strategic priorities, supported by our strong business fundamentals, will enable us to further accelerate growth, enhance profitability, and maximize cash flow through 2025 and beyond.”

Fourth Quarter Results

  • Revenue was reported at $437.8 million.
    • Housekeeping & laundry and dining & nutrition segment revenues and margins were $192.7 million and 10.2% and $245.1 million and 4.7%, respectively.
    • The Company expects mid-single digit revenue growth in 2025 and Q1 revenue in the range of $440.0 to $450.0 million.
  • Cost of services was reported at $379.2 million or 86.6%, inclusive of new business start-up costs.
    • The Company’s 2025 goal is to manage cost of services in the 86% range.
  • SG&A was reported at $44.8 million; after adjusting for the $0.4 million increase in deferred compensation, actual SG&A was $44.4 million or 10.1%, inclusive of new business start-up costs.
    • The Company’s 2025 goal is to manage SG&A into the 8.5% to 9.5% range.
  • Net income and diluted EPS were reported at $11.9 million and $0.16, inclusive of new business start-up costs.
  • Cash flow from operations was reported at $36.2 million; after adjusting for the $9.2 million increase in the payroll accrual, actual cash flow from operations was $27.0 million.
    • The Company estimates 2025 actual cash flow from operations, excluding the change in payroll accrual, in the range of $45.0 to $60.0 million.

Balance Sheet and Liquidity

The Company’s primary sources of liquidity are cash flow from operating activities, cash and cash equivalents, and its revolving credit facility. As of the end of the fourth quarter, the Company had cash and marketable securities of $135.8 million and a $500.0 million credit facility, inclusive of its $200.0 million accordion, which expires in November 2027.

Since the February 2023 share repurchase authorization, the Company has repurchased over $16.0 million of its common stock. The Company repurchased over $5.0 million of its common stock in 2024, including $1.0 million during the fourth quarter. The Company has 6.0 million shares remaining under its authorization.

Conference Call and Upcoming Events

The Company will host a conference call on Wednesday, February 12, 2025, at 8:30 a.m. Eastern Time to discuss its results for the three months ended December 31, 2024. The call may be accessed via phone at 1 (800) 715-9871, Conference ID: 9951274. The call will be simultaneously webcast under the “Events & Presentations” section of the Investor Relations page on the Company’s website, www.hcsg.com. A replay of the webcast will also be available on the website for one year following the date of the earnings call.

The Company will be participating in Oppenheimer’s 35th Annual Healthcare MedTech & Services Conference, which will be conducted virtually on March 19, 2025.

About Healthcare Services Group, Inc.

Healthcare Services Group (NASDAQ: HCSG) is an experienced leader in managing housekeeping, laundry, dining, and nutritional services within the healthcare industry. With more than 45 years of experience, HCSG aims to provide improved operational, regulatory, and financial outcomes for our clients.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This release and any schedules incorporated by reference into it may contain forward-looking statements within the meaning of federal securities laws, which are not historical facts but rather are based on current expectations, estimates and projections about our business and industry, and our beliefs and assumptions. Words such as “believes,” “anticipates,” “plans,” “expects,” “estimates,” “will,” “goal,” and similar expressions are intended to identify forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by us that any of our plans will be achieved. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Such forward-looking information is also subject to various risks and uncertainties. Such risks and uncertainties include, but are not limited to, risks arising from our providing services to the healthcare industry and primarily providers of long-term care; credit and collection risks associated with the healthcare industry; the impact of bank failures; our claims experience related to workers’ compensation, general liability and auto insurance; the effects of changes in, or interpretations of laws and regulations governing the healthcare industry, our workforce and services provided, including state and local regulations pertaining to the taxability of our services and other labor-related matters such as minimum wage increases; the Company’s expectations with respect to selling, general and administrative expense; the impacts of past or future cyber attacks or breaches; and the risk factors described in Part I of our Form 10-K for the fiscal year ended December 31, 2023 under “Government Regulation of Customers,” “Service Agreements and Collections,” and “Competition” and under Item IA. “Risk Factors” in such Form 10K.

These factors, in addition to delays in payments from customers and/or customers undergoing restructurings, have resulted in, and could continue to result in, significant additional bad debts in the near future. Additionally, our operating results have been in the past and could in the future be adversely affected by continued inflation particularly if increases in the costs of labor and labor-related costs, materials, supplies and equipment used in performing services (including the impact of potential tariffs) cannot be passed on to our customers.

In addition, we believe that to improve our financial performance we must continue to obtain service agreements with new customers, retain and provide new services to existing customers, achieve modest price increases on current service agreements with existing customers and/or maintain internal cost reduction strategies at our various operational levels. Furthermore, we believe that our ability to sustain the internal development of managerial personnel is an important factor impacting future operating results and the successful execution of our projected growth strategies. There can be no assurance that we will be successful in that regard.

USE OF NON-GAAP FINANCIAL INFORMATION

To supplement HCSG’s consolidated financial information, which are prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”), the Company believes that certain non-GAAP financial measures are useful in evaluating operating performance and comparing such performance to other companies.

The Company is presenting adjusted cash flows provided by operations, earnings before interest, taxes, depreciation and amortization (“EBITDA”) and EBITDA excluding items impacting comparability (“Adjusted EBITDA”). We cannot provide a reconciliation of forward-looking non-GAAP measures to GAAP due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliation. The presentation of non-GAAP financial measures is not meant to be considered in isolation or as a substitute for financial statements prepared in accordance with GAAP.

HEALTHCARE SERVICES GROUP, INC.

CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)

(in thousands, except per share data)

 

 

For the Three Months Ended

 

For the Year Ended

 

December 31,

 

December 31,

 

2024

 

2023

 

2024

 

2023

Revenue

$

437,812

 

$

423,840

 

$

1,715,682

 

$

1,671,389

Operating costs and expenses:

 

 

 

 

 

 

 

Cost of services

 

379,209

 

 

349,124

 

 

1,487,592

 

 

1,456,643

Selling, general and administrative

 

44,824

 

 

46,249

 

 

183,060

 

 

166,772

Income from operations

 

13,779

 

 

28,467

 

 

45,030

 

 

47,974

Other income, net

 

1,026

 

 

3,833

 

 

7,911

 

 

5,082

Income before income taxes

 

14,805

 

 

32,300

 

 

52,941

 

 

53,056

 

 

 

 

 

 

 

 

Income tax provision

 

2,885

 

 

8,792

 

 

13,470

 

 

14,670

Net income

$

11,920

 

$

23,508

 

$

39,471

 

$

38,386

 

 

 

 

 

 

 

 

Basic earnings per common share

$

0.16

 

$

0.32

 

$

0.54

 

$

0.52

 

 

 

 

 

 

 

 

Diluted earnings per common share

$

0.16

 

$

0.32

 

$

0.53

 

$

0.52

 

 

 

 

 

 

 

 

Basic weighted average number of common shares outstanding

 

73,553

 

 

73,817

 

 

73,754

 

 

74,288

 

 

 

 

 

 

 

 

Diluted weighted average number of common shares outstanding

 

73,934

 

 

73,879

 

 

73,988

 

 

74,340

HEALTHCARE SERVICES GROUP, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(in thousands)

 

 

December 31,

2024

 

December 31,

2023

Cash and cash equivalents

$

56,776

 

$

54,330

Restricted cash equivalents

 

3,355

 

 

Marketable securities, at fair value

 

50,535

 

 

93,131

Restricted marketable securities, at fair value

 

25,105

 

 

Accounts receivable, net

 

330,907

 

 

344,864

Notes receivable, net

 

51,429

 

 

38,645

Other current assets

 

38,545

 

 

40,726

Total current assets

 

556,652

 

 

571,696

 

 

 

 

Property and equipment, net

 

28,198

 

 

28,774

Notes receivable — long-term, net

 

41,054

 

 

24,832

Goodwill

 

75,529

 

 

75,529

Other intangible assets, net

 

9,442

 

 

12,127

Deferred compensation funding

 

49,639

 

 

40,812

Other assets

 

42,258

 

 

36,882

Total assets

$

802,772

 

$

790,652

 

 

 

 

Accrued insurance claims — current

$

25,148

 

$

22,681

Other current liabilities

 

167,399

 

 

194,247

Total current liabilities

 

192,547

 

 

216,928

 

 

 

 

Accrued insurance claims — long-term

 

51,869

 

 

61,697

Deferred compensation liability — long-term

 

50,011

 

 

41,186

Lease liability — long-term

 

8,033

 

 

11,235

Other long-term liabilities

 

385

 

 

2,990

 

 

 

 

Stockholders’ equity

 

499,927

 

 

456,616

Total liabilities and stockholders’ equity

$

802,772

 

$

790,652

HEALTHCARE SERVICES GROUP, INC.

RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES

(Unaudited)

 

Reconciliation of GAAP net income to EBITDA and adjusted EBITDA (in thousands)

 

For the Three Months Ended

 

For the Year Ended

 

December 31,

 

December 31,

 

2024

 

2023

 

2024

 

2023

GAAP net income

 

$

11,920

 

 

$

23,508

 

 

$

39,471

 

 

$

38,386

 

Income tax provision

 

 

2,885

 

 

 

8,792

 

 

 

13,470

 

 

 

14,670

 

Interest, net

 

 

(555

)

 

 

509

 

 

 

(424

)

 

 

1,629

 

Depreciation and amortization1

 

 

3,602

 

 

 

3,779

 

 

 

14,585

 

 

 

14,344

 

EBITDA

 

$

17,852

 

 

$

36,588

 

 

$

67,102

 

 

$

69,029

 

Share-based compensation

 

 

2,337

 

 

 

2,192

 

 

 

9,165

 

 

 

8,985

 

(Gain)/loss on deferred compensation, net2

 

 

(12

)

 

 

(28

)

 

 

(52

)

 

 

39

 

Adjusted EBITDA

 

$

20,177

 

 

$

38,752

 

 

$

76,215

 

 

$

78,053

 

Adjusted EBITDA as a percentage of revenue

 

 

4.6

%

 

 

9.1

%

 

 

4.4

%

 

 

4.7

%

Reconciliation of GAAP cash flows provided by operations to adjusted cash flows provided by operations (in thousands)

 

For the Three Months Ended

 

For the Year Ended

 

December 31,

 

December 31,

 

2024

 

2023

 

2024

 

2023

GAAP cash flows provided by operations

 

$

36,204

 

 

$

49,445

 

 

$

30,802

$

43,498

 

Accrued payroll3

 

 

(9,247

)

 

 

(21,563

)

 

 

3,573

 

(4,186

)

Adjusted cash flows provided by operations

 

$

26,957

 

 

$

27,882

 

 

$

34,375

$

39,312

 

1.

Includes right-of-use asset depreciation of $2.0 million and $7.8 million for the three and twelve months ended December 31, 2024, respectively, and $1.8 million and $6.4 million for the three and twelve months ended December 31, 2023.

2.

The Company offers a Supplemental Executive Retirement Plan (“SERP”) for executives and certain key employees which is also referred to as the Company’s “Deferred Compensation” plan. For SERP participants, the Company has historically retained, and anticipates continuing to retain, 100% of the funds received from SERP participants and holds such assets (the “Deferred Compensation Assets”) in a brokerage account where the investments are managed to mirror the investment elections of SERP participant holdings under such plans (the “Deferred Compensation Liabilities”). The Company’s changes in fair market value of the Deferred Compensation Assets are presented under the “Other income, net” caption on the Company’s Consolidated Statements of Comprehensive Income, however the corresponding and offsetting changes in the fair market value of the Deferred Compensation Liabilities are presented under the “Selling, general and administrative expense” caption.

3.

The accrued payroll adjustment reflects changes in accrued payroll for the three and twelve months ended December 31, 2024 and 2023. The Company processes payroll on set weekly and bi-weekly schedules, and the timing of payments may result in operating cash flow increases or decreases which are not indicative of the Company’s quarterly cash flow performance.

 

Theodore Wahl

President and Chief Executive Officer

Vikas Singh

Executive Vice President and Chief Financial Officer

Matthew J. McKee

Chief Communications Officer

215-639-4274

investor-relations@hcsgcorp.com

Source: Healthcare Services Group, Inc.

FAQ

What was HCSG's revenue and EPS for Q4 2024?

HCSG reported revenue of $437.8 million and diluted EPS of $0.16 for Q4 2024.

What is HCSG's revenue guidance for Q1 2025?

HCSG expects Q1 2025 revenue to be in the range of $440.0 to $450.0 million.

How much cash flow from operations did HCSG generate in Q4 2024?

HCSG reported cash flow from operations of $36.2 million, with actual cash flow of $27.0 million after adjusting for payroll accrual.

What is HCSG's share repurchase status as of Q4 2024?

HCSG has repurchased over $16.0 million of common stock since February 2023, including $5.0 million in 2024, with 6.0 million shares remaining under authorization.

What are HCSG's cost management targets for 2025?

HCSG aims to manage cost of services in the 86% range and SG&A in the 8.5% to 9.5% range for 2025.

Healthcare Svcs Group Inc

NASDAQ:HCSG

HCSG Rankings

HCSG Latest News

HCSG Stock Data

794.48M
72.11M
1.17%
103.04%
4.05%
Medical Care Facilities
Services-nursing & Personal Care Facilities
Link
United States
BENSALEM